18 results on '"Glant, Tibor T."'
Search Results
2. Collagen-induced arthritis is exacerbated in IL-10-deficient mice
- Author
-
Finnegan, Alison, Kaplan, Charles D, Cao, Yanxia, Eibel, Hermann, Glant, Tibor T, and Zhang, Jian
- Published
- 2002
- Full Text
- View/download PDF
3. Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis
- Author
-
Kaplan, Charles, Valdez, Juan C, Chandrasekaran, Raman, Eibel, Hermann, Mikecz, Katalin, Glant, Tibor T, and Finnegan, Alison
- Published
- 2001
- Full Text
- View/download PDF
4. Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis.
- Author
-
Hsu-Wen Tseng, Glant, Tibor T., Brown, Matthew A., Kenna, Tony J., Thomas, Gethin P., Pettit, Allison R., and Tseng, Hsu-Wen
- Subjects
- *
ANKYLOSING spondylitis , *DISEASE progression , *INFLAMMATION , *SPINE diseases , *RADIOGRAPHY , *PATIENTS , *ANIMAL experimentation , *ANTI-inflammatory agents , *BIOLOGICAL models , *COMBINATION drug therapy , *DRUG administration , *GLYCOPROTEINS , *MICE , *RESEARCH funding , *PREDNISOLONE - Abstract
Background: Ankylosing spondylitis (AS) is characterised by immune-mediated arthritis and osteoproliferation, ultimately leading to joint ankylosis. Whether inflammation is necessary for osteoproliferation is controversial, fuelled by the unclear efficacy of anti-inflammatory treatments on radiographic progression. In proteoglycan-induced spondylitis (PGISp), a mouse model of AS, inflammation is the prerequisite for osteoproliferation as osteoproliferation was only observed following inflammation-driven intervertebral disc (IVD) destruction. We hypothesised that early intervention with a potent anti-inflammatory therapy would protect IVD integrity and consequently alter disease progression.Methods: PGISp mice received vehicle or a combination of etanercept (ETN) plus prednisolone (PRD) therapy for 2 or 6 weeks initiated at an early disease stage. Peripheral arthritis was scored longitudinally. Spinal disease was assessed using a semi-quantitative histological scoring regimen including inflammation, joint destruction and excessive tissue formation.Results: ETN + PRD therapy significantly delayed the onset of peripheral arthritis. IVD integrity was significantly protected when treatment was commenced in early disease. Six-weeks of treatment resulted in trends towards reductions in intervertebral joint damage and excessive tissue formation. IVD score distribution was dichotomized, likely reflecting the extent of axial disease at initiation of therapy. In the sub-group of mice with high IVD destruction scores, ETN + PRD treatment significantly reduced IVD destruction severity, inflammation and bone erosion and reduced cartilage damage and excessive tissue formation.Conclusions: Early intervention with anti-inflammatory treatment not only improved inflammatory symptoms but also ameliorated structural damage of spine in PGISp mice. This preclinical observation suggests that early anti-inflammatory intervention may slow radiographic progression in AS patients. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
5. Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes.
- Author
-
Hsu-Wen Tseng, Pitt, Miranda E., Glant, Tibor T., McRae, Allan F., Kenna, Tony J., Brown, Matthew A., Pettit, Allison R., and Thomas, Gethin P.
- Published
- 2016
- Full Text
- View/download PDF
6. Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.
- Author
-
Haynes, Katelin R., Hsu-Wen Tseng, Kneissel, Michaela, Glant, Tibor T., Brown, Matthew A., Thomas, Gethin P., and Tseng, Hsu-Wen
- Subjects
ANKYLOSING spondylitis ,SCLEROSTIN ,DISEASE progression ,LABORATORY mice ,WNT genes ,OSTEOCYTES ,CARTILAGE cells ,DOWNREGULATION ,SUBCUTANEOUS injections ,ANIMAL experimentation ,BIOLOGICAL models ,BONE morphogenetic proteins ,EPITHELIAL cells ,MICE ,GENETIC markers ,TREATMENT effectiveness - Abstract
Background: No treatment to date is available which specifically targets bone formation in ankylosing spondylitis (AS). Several recent studies have shown that sclerostin (SOST), a Wnt inhibitor specific to osteocytes and chondrocytes, is down-regulated in AS patients. This suggests Wnt signalling may be upregulated, and application of exogenous recombinant SOST (rSOST) may inhibit Wnt signalling and slow pathological bone formation.Methods: The proteoglycan-induced spondylitis (PGISp) mouse model in which we have previously demonstrated downregulated SOST expression, was used for this study. Mice were injected with 2.5 ug rSOST/day for a period of 8 weeks following induction of disease. Axial skeleton disease development was assessed by histology and skeletal changes examined using DEXA.Results: rSOST treatment had no effect on peripheral or axial disease development, bone density or disease severity. Injected rSOST was stable over 8 h and residual levels were evident 24 h after injection, resulting in a cumulative increase in SOST serum levels over the treatment time course. Immunohistochemical examination of SOST levels within the joints in non-rSOST treated PGISp mice showed a significant decrease in the percentage of positive osteocytes in the unaffected joints compared to the affected joints, while no difference was seen in rSOST treated mice. This suggests that rSOST treatment increases the number of SOST-positive osteocytes in unaffected joints but not affected joints, despite having no impact on the number of joints affected by disease.Conclusions: Although not disease-modifying, rSOST treatment did appear to regulate SOST levels in the joints suggesting biological activity. Further dose response studies are required and SOST may require modifications to improve its bone targeting ability in order to affect tissue formation to a meaningful level in this model. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
7. Epigenetics in the pathogenesis of rheumatoid arthritis.
- Author
-
Glant, Tibor T., Mikecz, Katalin, and Rauch, Tibor A.
- Abstract
An increasing number of studies show that besides the inherited genetic architecture (that is, genomic DNA), various environmental factors significantly contribute to the etiology of rheumatoid arthritis. Epigenetic factors react to external stimuli and form bridges between the environment and the genetic information-harboring DNA. Epigenetic mechanisms are implicated in the final interpretation of the encoded genetic information by regulating gene expression, and alterations in their profile influence the activity of the immune system. Overall, epigenetic mechanisms further increase the well-known complexity of rheumatoid arthritis by providing additional subtle contributions to rheumatoid arthritis susceptibility. Although there are controversies regarding the involvement of epigenetic and genetic factors in rheumatoid arthritis etiology, it is becoming obvious that the two systems (genetic and epigenetic) interact with each other and are ultimately responsible for rheumatoid arthritis development. Here, epigenetic factors and mechanisms involved in rheumatoid arthritis are reviewed and new, potential therapeutic targets are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
8. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors.
- Author
-
Haynes, Katelin R., Pettit, Allison R., Duan, Ran, Hsu-Wen Tseng, Glant, Tibor T., Brown, Matthew A., and Thomas, Gethin P.
- Published
- 2012
- Full Text
- View/download PDF
9. Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study.
- Author
-
Kurkó, Júlia, Vida, András, Glant, Tibor T, Scanzello, Carla R, Katz, Robert S, Nair, Anjali, Mikecz, Katalin, and Szekanecz, Zoltán
- Abstract
Background: Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of innate immune cells with a granulocyte-like or monocyte-like phenotype and a unique ability to suppress T-cell responses. MDSCs have been shown to accumulate in cancer patients, but recent studies suggest that these cells are also present in humans and animals suffering from autoimmune diseases. We previously identified MDSCs in the synovial fluid (SF) of mice with experimental autoimmune arthritis. The goal of the present study was to identify MDSCs in the SF of patients with rheumatoid arthritis (RA).Methods: RA SF cells were studied by flow cytometry using antibodies to MDSC cell surface markers as well as by analysis of cell morphology. The suppressor activity of RA SF cells toward autologous peripheral blood T cells was determined ex vivo. We employed both antigen-nonspecific (anti-CD3/CD28 antibodies) and antigen-specific (allogeneic cells) induction systems to test the effects of RA SF cells on the proliferation of autologous T cells.Results: SF from RA patients contained MDSC-like cells, the majority of which showed granulocyte (neutrophil)-like phenotype and morphology. RA SF cells significantly suppressed the proliferation of anti-CD3/CD28-stimulated autologous T cells upon co-culture. When compared side by side, RA SF cells had a more profound inhibitory effect on the alloantigen-induced than the anti-CD3/CD28-induced proliferation of autologous T cells.Conclusion: MDSCs are present among RA SF cells that are commonly regarded as inflammatory neutrophils. Our results suggest that the presence of neutrophil-like MDSCs in the SF is likely beneficial, as these cells have the ability to limit the expansion of joint-infiltrating T cells in RA. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
10. Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis.
- Author
-
Tseng HW, Glant TT, Brown MA, Kenna TJ, Thomas GP, and Pettit AR
- Subjects
- Animals, Drug Administration Schedule, Drug Therapy, Combination, Etanercept administration & dosage, Female, Humans, Mice, Mice, Inbred BALB C, Prednisolone administration & dosage, Spondylitis, Ankylosing pathology, Anti-Inflammatory Agents administration & dosage, Disease Models, Animal, Proteoglycans toxicity, Spondylitis, Ankylosing chemically induced, Spondylitis, Ankylosing drug therapy
- Abstract
Background: Ankylosing spondylitis (AS) is characterised by immune-mediated arthritis and osteoproliferation, ultimately leading to joint ankylosis. Whether inflammation is necessary for osteoproliferation is controversial, fuelled by the unclear efficacy of anti-inflammatory treatments on radiographic progression. In proteoglycan-induced spondylitis (PGISp), a mouse model of AS, inflammation is the prerequisite for osteoproliferation as osteoproliferation was only observed following inflammation-driven intervertebral disc (IVD) destruction. We hypothesised that early intervention with a potent anti-inflammatory therapy would protect IVD integrity and consequently alter disease progression., Methods: PGISp mice received vehicle or a combination of etanercept (ETN) plus prednisolone (PRD) therapy for 2 or 6 weeks initiated at an early disease stage. Peripheral arthritis was scored longitudinally. Spinal disease was assessed using a semi-quantitative histological scoring regimen including inflammation, joint destruction and excessive tissue formation., Results: ETN + PRD therapy significantly delayed the onset of peripheral arthritis. IVD integrity was significantly protected when treatment was commenced in early disease. Six-weeks of treatment resulted in trends towards reductions in intervertebral joint damage and excessive tissue formation. IVD score distribution was dichotomized, likely reflecting the extent of axial disease at initiation of therapy. In the sub-group of mice with high IVD destruction scores, ETN + PRD treatment significantly reduced IVD destruction severity, inflammation and bone erosion and reduced cartilage damage and excessive tissue formation., Conclusions: Early intervention with anti-inflammatory treatment not only improved inflammatory symptoms but also ameliorated structural damage of spine in PGISp mice. This preclinical observation suggests that early anti-inflammatory intervention may slow radiographic progression in AS patients.
- Published
- 2017
- Full Text
- View/download PDF
11. Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes.
- Author
-
Tseng HW, Pitt ME, Glant TT, McRae AF, Kenna TJ, Brown MA, Pettit AR, and Thomas GP
- Subjects
- Animals, Female, Inflammation complications, Inflammation pathology, Mice, Mice, Inbred BALB C, Mice, Knockout, Disease Models, Animal, Disease Progression, Osteogenesis physiology, Spondylitis, Ankylosing etiology, Spondylitis, Ankylosing pathology
- Abstract
Background: Ankylosing spondylitis (AS) is an immune-mediated arthritis particularly targeting the spine and pelvis and is characterised by inflammation, osteoproliferation and frequently ankylosis. Current treatments that predominately target inflammatory pathways have disappointing efficacy in slowing disease progression. Thus, a better understanding of the causal association and pathological progression from inflammation to bone formation, particularly whether inflammation directly initiates osteoproliferation, is required., Methods: The proteoglycan-induced spondylitis (PGISp) mouse model of AS was used to histopathologically map the progressive axial disease events, assess molecular changes during disease progression and define disease progression using unbiased clustering of semi-quantitative histology. PGISp mice were followed over a 24-week time course. Spinal disease was assessed using a novel semi-quantitative histological scoring system that independently evaluated the breadth of pathological features associated with PGISp axial disease, including inflammation, joint destruction and excessive tissue formation (osteoproliferation). Matrix components were identified using immunohistochemistry., Results: Disease initiated with inflammation at the periphery of the intervertebral disc (IVD) adjacent to the longitudinal ligament, reminiscent of enthesitis, and was associated with upregulated tumor necrosis factor and metalloproteinases. After a lag phase, established inflammation was temporospatially associated with destruction of IVDs, cartilage and bone. At later time points, advanced disease was characterised by substantially reduced inflammation, excessive tissue formation and ectopic chondrocyte expansion. These distinct features differentiated affected mice into early, intermediate and advanced disease stages. Excessive tissue formation was observed in vertebral joints only if the IVD was destroyed as a consequence of the early inflammation. Ectopic excessive tissue was predominantly chondroidal with chondrocyte-like cells embedded within collagen type II- and X-rich matrix. This corresponded with upregulation of mRNA for cartilage markers Col2a1, sox9 and Comp. Osteophytes, though infrequent, were more prevalent in later disease., Conclusions: The inflammation-driven IVD destruction was shown to be a prerequisite for axial disease progression to osteoproliferation in the PGISp mouse. Osteoproliferation led to vertebral body deformity and fusion but was never seen concurrent with persistent inflammation, suggesting a sequential process. The findings support that early intervention with anti-inflammatory therapies will be needed to limit destructive processes and consequently prevent progression of AS.
- Published
- 2016
- Full Text
- View/download PDF
12. Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis.
- Author
-
Kezic JM, Glant TT, Rosenbaum JT, and Rosenzweig HL
- Subjects
- Aggrecans immunology, Animals, Antibodies, Neutralizing immunology, Cells, Cultured, Cytokines immunology, Cytokines metabolism, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Female, Humans, Interferon-gamma deficiency, Interferon-gamma genetics, Interferon-gamma immunology, Interleukin-17 immunology, Interleukin-17 metabolism, Male, Mice, Mice, Inbred BALB C, Mice, Knockout, Mice, Transgenic, Photoreceptor Cells, Vertebrate immunology, Photoreceptor Cells, Vertebrate pathology, Receptors, Antigen, T-Cell genetics, Receptors, Antigen, T-Cell immunology, Receptors, Antigen, T-Cell metabolism, Spondylarthritis immunology, T-Lymphocytes drug effects, T-Lymphocytes immunology, T-Lymphocytes metabolism, Uveitis complications, Uveitis immunology, Antibodies, Neutralizing pharmacology, Interleukin-17 antagonists & inhibitors, Photoreceptor Cells, Vertebrate drug effects, Spondylarthritis complications, Uveitis prevention & control
- Abstract
Introduction: Uveitis, or intraocular inflammatory disease, is a frequent extra-articular manifestation of several forms of arthritis. Despite the frequent co-occurrence of uveitis and arthritis, little is understood of the eye's predisposition to this disease. We recently described a previously unreported uveitis in a murine model of spondyloarthropathy triggered by autoimmunity to aggrecan, a prominent proteoglycan (PG) macromolecule in cartilage. In contrast to the joint and spine, wherein interferon-gamma (IFNγ) deficiency reduced disease, IFNγ deficiency worsened uveitis. Given the regulatory role of IFNγ on the Th17 response and the current focus of anti-interleukin-17 therapeutics in patients with uveitis and spondyloarthritis, we sought to determine the extent to which interleukin (IL)-17 mediates uveitis in the absence of IFNγ., Methods: Antigen specific T cell cytokine production was measured in splenocyte cultures using multiplex-ELISA. Transgenic (Tg) mice expressing the T cell receptor (TCR) recognizing the dominant arthritogenic epitope in the G1 domain of PG (TCR-Tg), also lacking IFNγ, were immunized with PG. Mice were then systemically administered an anti-IL-17 neutralizing antibody. The onset and severity of peripheral arthritis was evaluated by clinical scoring criteria and histology. Uveitis was assessed using intravital videomicroscopy, which visualizes leukocyte trafficking within the vasculature and tissue of the iris, and by histology., Results: TCR-Tg splenocytes stimulated in vitro with recombinant G1 peptide demonstrated exacerbated production of cytokines, such as macrophage inflammatory protein (MIP)-1α, MIP-1β, IL-1β, and most notably IL-17A as a consequence of IFNγ deficiency. In vivo, IL-17 inhibition prevented the component of PG-induced arthritis that occurs independently of IFNγ. Blockade of IL-17 ameliorated the ongoing leukocyte trafficking responses within the iris vasculature and tissue, which coincided with reduced infiltration of leukocytes within the anterior and posterior eye segments. However, the anti-IL-17 treatment resulted in unanticipated photoreceptor toxicity., Conclusions: These data support a protective, regulatory role for IFNγ in suppression of IL-17-mediated intraocular disease and to a lesser extent, joint disease. The unanticipated photoreceptor toxicity raises some caution regarding the use of anti-IL-17 therapeutics until the mechanism of this potential effect is determined.
- Published
- 2012
- Full Text
- View/download PDF
13. Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.
- Author
-
Angyal A, Egelston C, Kobezda T, Olasz K, László A, Glant TT, and Mikecz K
- Subjects
- Adoptive Transfer, Animals, Antigen-Presenting Cells immunology, Antigen-Presenting Cells pathology, Arthritis, Experimental chemically induced, Arthritis, Experimental pathology, Arthritis, Rheumatoid chemically induced, Arthritis, Rheumatoid pathology, Cell Movement, Female, Fingolimod Hydrochloride, Gene Knock-In Techniques, Humans, Immunosuppressive Agents pharmacology, Joints pathology, Lymph Nodes immunology, Lymph Nodes pathology, Male, Mice, Mice, Inbred BALB C, Mice, SCID, Propylene Glycols pharmacology, Proteoglycans pharmacology, Sphingosine analogs & derivatives, Sphingosine pharmacology, T-Lymphocytes drug effects, T-Lymphocytes pathology, Arthritis, Experimental immunology, Arthritis, Rheumatoid immunology, Autoantibodies immunology, Joints immunology, Proteoglycans immunology, T-Lymphocytes immunology
- Abstract
Introduction: Inflammatory joint destruction in rheumatoid arthritis (RA) may be triggered by autoantibodies, the production of which is supported by autoreactive T cells. Studies on RA and animal models of the disease suggest that T cells recruited in the joints can locally initiate or propagate arthritis. Herein, we investigated the role of joint-homing versus lymphoid organ-homing T cells in the development of proteoglycan-induced arthritis (PGIA), an autoimmune model of RA., Methods: To identify T cells migrating to the joints before and during development of autoimmune arthritis, we transferred fluorescence-labeled T cells, along with antigen-presenting cells, from BALB/c mice with PGIA to naïve syngeneic severe combined immunodeficient (SCID) mice. We then monitored the recruitment of donor T cells in the ankle joints and joint-draining lymph nodes of the recipients using in vivo two-photon microscopy and ex vivo detection methods. To limit T-cell access to the joints, we selectively depleted T cells in the blood circulation by treatment with FTY720, an inhibitor of lymphocyte egress from lymphoid organs. Reduction of T cell presence in both lymphoid organs and blood was achieved by injection of donor cells from which T cells were removed prior to transfer. T and B cells were quantitated by flow cytometry, and antigen (PG)-specific responses were assessed by cell proliferation and serum antibody assays., Results: Despite development of adoptively transferred arthritis in the recipient SCID mice, we found very few donor T cells in their joints after cell transfer. Treatment of recipient mice with FTY720 left the T-cell pool in the lymphoid organs intact, but reduced T cells in both peripheral blood and joints. However, FTY720 treatment failed to inhibit PGIA development. In contrast, arthritis was not seen in recipient mice after transfer of T cell-depleted cells from arthritic donors, and serum autoantibodies to PG were not detected in this group of mice., Conclusions: Our results suggest that antigen-specific T cells, which home to lymphoid organs and provide help to B cells for systemic autoantibody production, play a greater role in the development and progression of autoimmune arthritis than the small population of T cells that migrate to the joints.
- Published
- 2010
- Full Text
- View/download PDF
14. Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis.
- Author
-
Tarjanyi O, Boldizsar F, Nemeth P, Mikecz K, and Glant TT
- Abstract
Background: Rheumatoid arthritis (RA) most often begins in females in the fourth-fifth decade of their life, suggesting that the aging of the immune system (immunosenescence) has a major role in this disease. Therefore, in the present study, we sought to investigate the effect of age on arthritis susceptibility in BALB/c mice using the proteoglycan (PG)-induced arthritis (PGIA) model of RA., Results: We have found that young, 1-month-old female BALB/c mice are resistant to the induction of PGIA, but with aging they become susceptible. PG-induced T cell responses decline with age, whereas there is a shift toward Th1 cytokines. An age-dependent decrease in T cell number is associated with an increased ratio of the memory phenotype, and lower CD28 expression. Antigen-presenting cells shifted from macrophages and myeloid dendritic cells in young mice toward B cells in older mice. The regulatory/activated T cell ratio decreases in older mice after PG injections indicating impaired regulation of the immune response., Conclusion: We conclude that immunosenescence could alter arthritis susceptibility in a very complex manner including both adaptive and innate immunities, and it cannot be determined by a single trait. Cumulative alterations in immunoregulatory functions closely resemble human disease, which makes this systemic autoimmune arthritis model of RA even more valuable.
- Published
- 2009
- Full Text
- View/download PDF
15. BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance.
- Author
-
Farkas B, Boldizsar F, Tarjanyi O, Laszlo A, Lin SM, Hutas G, Tryniszewska B, Mangold A, Nagyeri G, Rosenzweig HL, Finnegan A, Mikecz K, and Glant TT
- Subjects
- Animals, Arthritis, Experimental pathology, Cytokines blood, Cytokines immunology, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Female, Gene Expression, Genetic Predisposition to Disease, Humans, In Situ Hybridization, Mice, Mice, Inbred BALB C, Oligonucleotide Array Sequence Analysis, Phenotype, Polymorphism, Single Nucleotide, Spondylitis, Ankylosing pathology, Arthritis, Experimental genetics, Arthritis, Experimental immunology, Penetrance, Proteoglycans immunology, Spondylitis, Ankylosing genetics, Spondylitis, Ankylosing immunology
- Abstract
Introduction: The major histocompatibility complex (H-2d) and non-major histocompatibility complex genetic backgrounds make the BALB/c strain highly susceptible to inflammatory arthritis and spondylitis. Although different BALB/c colonies develop proteoglycan-induced arthritis and proteoglycan-induced spondylitis in response to immunization with human cartilage proteoglycan, they show significant differences in disease penetrance despite being maintained by the same vendor at either the same or a different location., Methods: BALB/c female mice (24 to 26 weeks old after 4 weeks of acclimatization) were immunized with a suboptimal dose of cartilage proteoglycan to explore even minute differences among 11 subcolonies purchased from five different vendors. In vitro-measured T-cell responses, and serum cytokines and (auto)antibodies were correlated with arthritis (and spondylitis) phenotypic scores. cDNA microarrays were also performed using spleen cells of naïve and immunized BALB/cJ and BALB/cByJ mice (both colonies from The Jackson Laboratory, Bar Harbor, ME, USA), which represent the two major BALB/c sublines., Results: The 11 BALB/c colonies could be separated into high (n = 3), average (n = 6), and low (n = 2) responder groups based upon their arthritis scores. While the clinical phenotypes showed significant differences, only a few immune parameters correlated with clinical or histopathological abnormalities, and seemingly none of them affected differences found in altered clinical phenotypes (onset time, severity or incidence of arthritis, or severity and progression of spondylitis). Affymetrix assay (Affymetrix, Santa Clara, CA, USA) explored 77 differentially expressed genes (at a significant level, P < 0.05) between The Jackson Laboratory's BALB/cJ (original) and BALB/cByJ (transferred from the National Institutes of Health, Bethesda, MD, USA). Fourteen of the 77 differentially expressed genes had unknown function; 24 of 77 genes showed over twofold differences, and only 8 genes were induced by immunization, some in both colonies., Conclusions: Using different subcolonies of the BALB/c strain, we can detect significant differences in arthritis phenotypes, single-nucleotide polymorphisms (SNPs), and a large number of differentially expressed genes, even in non-immunized animals. A number of the known genes (and SNPs) are associated with immune responses and/or arthritis in this genetically arthritis-prone murine strain, and a number of genes of as-yet-unknown function may affect or modify clinical phenotypes of arthritis and/or spondylitis.
- Published
- 2009
- Full Text
- View/download PDF
16. Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice.
- Author
-
Szántó S, Koreny T, Mikecz K, Glant TT, Szekanecz Z, and Varga J
- Subjects
- Animals, Chromatography, High Pressure Liquid, Feedback, Physiological, Humans, Interleukin-2 biosynthesis, Kynuramine blood, Mice, Mice, Inbred DBA, T-Lymphocytes immunology, Tryptophan analogs & derivatives, Tryptophan pharmacology, Arthritis, Experimental enzymology, Arthritis, Experimental immunology, Arthritis, Experimental pathology, Indoleamine-Pyrrole 2,3,-Dioxygenase metabolism, Tryptophan metabolism
- Abstract
Indoleamine 2,3-dioxygenase (IDO) is one of the initial and rate-limiting enzymes involved in the catabolism of the essential amino acid tryptophan. In cultured cells, the induction of IDO leads to depletion of tryptophan and tryptophan starvation. Recent studies suggest that modulation of tryptophan concentration via IDO plays a fundamental role in innate immune responses. Induction of IDO by interferon-gamma in macrophages and dendritic cells results in tryptophan depletion and suppresses the immune-mediated activation of fibroblasts and T, B, and natural killer cells. To assess the role of IDO in collagen-induced arthritis (CIA), a model of rheumatoid arthritis characterized by a primarily Th1-like immune response, activity of IDO was inhibited by 1-methyl-tryptophan (1-MT) in vivo. The results showed significantly increased incidence and severity of CIA in mice treated with 1-MT. Activity of IDO, as determined by measuring the levels of kynurenine/tryptophan ratio in the sera, was increased in the acute phase of arthritis and was higher in collagen-immunized mice that did not develop arthritis. Treatment with 1-MT resulted in an enhanced cellular and humoral immune response and a more dominant polarization to Th1 in mice with arthritis compared with vehicle-treated arthritic mice. The results demonstrated that development of CIA was associated with increased IDO activity and enhanced tryptophan catabolism in mice. Blocking IDO with 1-MT aggravated the severity of arthritis and enhanced the immune responses. These findings suggest that IDO may play an important and novel role in the negative feedback of CIA and possibly in the pathogenesis of rheumatoid arthritis.
- Published
- 2007
- Full Text
- View/download PDF
17. Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation.
- Author
-
Adarichev VA, Vermes C, Hanyecz A, Mikecz K, Bremer EG, and Glant TT
- Subjects
- Acute Disease, Adoptive Transfer, Animals, Arthritis, Experimental etiology, Arthritis, Experimental immunology, Autoimmune Diseases etiology, Autoimmune Diseases immunology, Chemokines biosynthesis, Chemokines genetics, Chronic Disease, Disease Progression, Female, Gene Expression Regulation, Humans, Interferon-gamma biosynthesis, Interferon-gamma genetics, Lymphocyte Activation genetics, Mice, Mice, Inbred BALB C, Mice, SCID, Oligonucleotide Array Sequence Analysis, Proteoglycans immunology, Spleen immunology, T-Lymphocyte Subsets immunology, Tumor Necrosis Factor-alpha biosynthesis, Tumor Necrosis Factor-alpha genetics, Arthritis, Experimental genetics, Autoimmune Diseases genetics, Gene Expression Profiling
- Abstract
We present here an extensive study of differential gene expression in the initiation, acute and chronic phases of murine autoimmune arthritis with the use of high-density oligonucleotide arrays interrogating the entire mouse genome. Arthritis was induced in severe combined immunodeficient mice by using adoptive transfer of lymphocytes from proteoglycan-immunized arthritic BALB/c mice. In this unique system only proteoglycan-specific lymphocytes are transferred from arthritic mice into syngeneic immunodeficient recipients that lack adaptive immunity but have intact innate immunity on an identical (BALB/c) genetic background.Differential gene expression in response to donor lymphocytes that migrated into the joint can therefore be monitored in a precisely timed manner, even before the onset of inflammation. The initiation phase of adoptively transferred disease (several days before the onset of joint swelling) was characterized by differential expression of 37 genes, mostly related to chemokines, interferon-gamma and tumor necrosis factor-alpha signaling, and T cell functions. These were designated early arthritis 'signature' genes because they could distinguish between the naive and the pre-arthritic state. Acute joint inflammation was characterized by at least twofold overexpression of 256 genes and the downregulation of 21 genes, whereas in chronic arthritis a total of 418 genes with an equal proportion of upregulated and downregulated transcripts were expressed differentially. Hierarchical clustering and functional classification of inflammation-related and arthritis-related genes indicated that the most common biological activities were represented by genes encoding interleukins, chemokine receptors and ligands, and by those involved in antigen recognition and processing.
- Published
- 2005
- Full Text
- View/download PDF
18. Collagen-induced arthritis is exacerbated in IL-10-deficient mice.
- Author
-
Finnegan A, Kaplan CD, Cao Y, Eibel H, Glant TT, and Zhang J
- Subjects
- Animals, Antibody Formation, Arthritis chemically induced, Arthritis pathology, CD11b Antigen analysis, Cell Division, Cells, Cultured, Collagen immunology, Disease Progression, Interferon-gamma biosynthesis, Interleukin-10 genetics, Mice, Mice, Inbred DBA, Mice, Knockout, Spleen cytology, Arthritis immunology, Interleukin-10 physiology
- Abstract
IL-10 is a potent immunoregulatory cytokine attenuating a wide range of immune effector and inflammatory responses. In the present study, we assess whether endogenous levels of IL-10 function to regulate the incidence and severity of collagen-induced arthritis. DBA/1 wildtype (WT), heterozygous (IL-10+/-) and homozygous (IL-10-/-) IL-10-deficient mice were immunized with type II collagen. Development of arthritis was monitored over time, and collagen-specific cytokine production and anticollagen antibodies were assessed. Arthritis developed progressively in mice immunized with collagen, and 100% of the WT, IL-10+/-, and IL-10-/- mice were arthritic at 35 days. However, the severity of arthritis in the IL-10-/- mice was significantly greater than that in WT or IL-1+/- animals. Disease severity was associated with reduced IFN-gamma levels and a dramatic increase in CD11b-positive macrophages. Paradoxically, both the IgG1 and IgG2a anticollagen antibody responses were also significantly reduced. These data demonstrate that IL-10 is capable of controlling disease severity through a mechanism that involves IFN-gamma. Since IL-10 levels are elevated in rheumatoid arthritis synovial fluid, these findings may have relevance to rheumatoid arthritis.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.